Abpro Inc (ABPWW)
0.04
-0.00 (-6.98%)
At close: Apr 10, 2025, 9:40 AM
0.04
0.00%
After-hours: Apr 10, 2025, 04:00 PM EDT
-6.98% (1D)
| Bid | 0.04 |
| Market Cap | 26.55M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.05 |
| Volume | 6,185 |
| Avg. Volume (20D) | 39,365.18 |
| Open | 0.04 |
| Previous Close | 0.04 |
| Day's Range | 0.04 - 0.04 |
| 52-Week Range | 0.04 - 0.04 |
| Beta | -0.08 |
About ABPWW
Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 15
Stock Exchange NASDAQ
Ticker Symbol ABPWW
Website https://abpro.com